Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Carisma Therapeutics Inc. (SESN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/22/2023 |
SC 13D/A
| HealthCap VII, L.P. reports a 8.4% stake in CARISMA THERAPEUTICS INC. |
| 01/26/2023 |
SC 13D/A
| Radoff Bradley Louis reports a 4.4% stake in Sesen Bio, Inc. |
| 01/05/2023 |
SC 13D/A
| Radoff Bradley Louis reports a 4.3% stake in Sesen Bio, Inc. |
| 12/01/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/07/2017 |
SC 13D/A
| Flagship Ventures Fund 2007, L.P. reports a 4.3% stake in Eleven Biotherapeutics, Inc. |
| 11/30/2016 |
SC 13D/A
| Flagship Ventures Fund 2007, L.P. reports a 5.8% stake in Eleven Biotherapeutics, Inc. |
| 11/18/2016 |
SC 13D/A
| Flagship Ventures Fund 2007, L.P. reports a 6.9% stake in Eleven Biotherapeutics, Inc. |
| 09/23/2016 |
SC 13D/A
| Flagship Ventures Fund 2007, L.P. reports a 10.1% stake in Eleven Biotherapeutics, Inc. |
| 09/19/2016 |
SC 13D/A
| Flagship Ventures Fund 2007, L.P. reports a 15.9% stake in Eleven Biotherapeutics, Inc. |
|
|